CPZ and neoplasm: The analysis and visualization of the data indicated that some anti-tumor drugs had significantly higher IC50 values in the group with high expression of CPZ than in the group with low expression of CPZ, such as oxaliplatin, cisplatin, docetaxel, afatinib, erlotinib, gefitinib, lapatinib, and cytarabine (Figures 8A–H).